These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 18245669)

  • 1. A cell-active inhibitor of mitogen-activated protein kinase phosphatases restores paclitaxel-induced apoptosis in dexamethasone-protected cancer cells.
    Vogt A; McDonald PR; Tamewitz A; Sikorski RP; Wipf P; Skoko JJ; Lazo JS
    Mol Cancer Ther; 2008 Feb; 7(2):330-40. PubMed ID: 18245669
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1.
    Vogt A; Tamewitz A; Skoko J; Sikorski RP; Giuliano KA; Lazo JS
    J Biol Chem; 2005 May; 280(19):19078-86. PubMed ID: 15753082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cdc25B dual-specificity phosphatase inhibitors identified in a high-throughput screen of the NIH compound library.
    Johnston PA; Foster CA; Tierno MB; Shun TY; Shinde SN; Paquette WD; Brummond KM; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2009 Jun; 7(3):250-65. PubMed ID: 19530895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NSC 95397 Suppresses Proliferation and Induces Apoptosis in Colon Cancer Cells through MKP-1 and the ERK1/2 Pathway.
    Dubey NK; Peng BY; Lin CM; Wang PD; Wang JR; Chan CH; Wei HJ; Deng WP
    Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29857489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
    Wu W; Pew T; Zou M; Pang D; Conzen SD
    J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.
    Small GW; Shi YY; Higgins LS; Orlowski RZ
    Cancer Res; 2007 May; 67(9):4459-66. PubMed ID: 17483361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.
    Kaltenmeier CT; Vollmer LL; Vernetti LA; Caprio L; Davis K; Korotchenko VN; Day BW; Tsang M; Hulkower KI; Lotze MT; Vogt A
    J Pharmacol Exp Ther; 2017 Apr; 361(1):39-50. PubMed ID: 28154014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone causes sustained expression of mitogen-activated protein kinase (MAPK) phosphatase 1 and phosphatase-mediated inhibition of MAPK p38.
    Lasa M; Abraham SM; Boucheron C; Saklatvala J; Clark AR
    Mol Cell Biol; 2002 Nov; 22(22):7802-11. PubMed ID: 12391149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plumbagin induces apoptosis in lymphoma cells via oxidative stress mediated glutathionylation and inhibition of mitogen-activated protein kinase phosphatases (MKP1/2).
    Checker R; Gambhir L; Sharma D; Kumar M; Sandur SK
    Cancer Lett; 2015 Feb; 357(1):265-278. PubMed ID: 25444924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level of mitogen-activated protein kinase phosphatase-1 expression is associated with cisplatin resistance in osteosarcoma.
    Wang Z; Zhou JY; Kanakapalli D; Buck S; Wu GS; Ravindranath Y
    Pediatr Blood Cancer; 2008 Dec; 51(6):754-9. PubMed ID: 18726921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel hydroxyl naphthoquinones with potent Cdc25 antagonizing and growth inhibitory properties.
    Peyregne VP; Kar S; Ham SW; Wang M; Wang Z; Carr BI
    Mol Cancer Ther; 2005 Apr; 4(4):595-602. PubMed ID: 15827333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
    Srivastava N; Sudan R; Saha B
    J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer.
    Rincón R; Zazo S; Chamizo C; Manso R; González-Alonso P; Martín-Aparicio E; Cristóbal I; Cañadas C; Perona R; Lluch A; Eroles P; García-Foncillas J; Albanell J; Rovira A; Madoz-Gúrpide J; Rojo F
    Mol Cancer Ther; 2016 Nov; 15(11):2780-2790. PubMed ID: 27599524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compartment-specific regulation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinases (MAPKs) by ERK-dependent and non-ERK-dependent inductions of MAPK phosphatase (MKP)-3 and MKP-1 in differentiating P19 cells.
    Reffas S; Schlegel W
    Biochem J; 2000 Dec; 352 Pt 3(Pt 3):701-8. PubMed ID: 11104676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogen-activated protein kinase (MAPK) phosphatase-1 and -4 attenuate p38 MAPK during dexamethasone-induced insulin resistance in 3T3-L1 adipocytes.
    Bazuine M; Carlotti F; Tafrechi RS; Hoeben RC; Maassen JA
    Mol Endocrinol; 2004 Jul; 18(7):1697-707. PubMed ID: 15184525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel benzofuran inhibitors of human mitogen-activated protein kinase phosphatase-1.
    Lazo JS; Nunes R; Skoko JJ; Queiroz de Oliveira PE; Vogt A; Wipf P
    Bioorg Med Chem; 2006 Aug; 14(16):5643-50. PubMed ID: 16698271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of c-Jun N-terminal kinase and p38 kinase pathways in endothelial cells.
    Wadgaonkar R; Pierce JW; Somnay K; Damico RL; Crow MT; Collins T; Garcia JG
    Am J Respir Cell Mol Biol; 2004 Oct; 31(4):423-31. PubMed ID: 15231489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin regulates MAP kinase phosphatase-1 induction in Hirc B cells via activation of both extracellular signal-regulated kinase (ERK) and c-Jun-N-terminal kinase (JNK).
    Byon JC; Dadke SS; Rulli S; Kusari AB; Kusari J
    Mol Cell Biochem; 2001 Feb; 218(1-2):131-8. PubMed ID: 11330828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and implementation of a 384-well homogeneous fluorescence intensity high-throughput screening assay to identify mitogen-activated protein kinase phosphatase-1 dual-specificity protein phosphatase inhibitors.
    Johnston PA; Foster CA; Shun TY; Skoko JJ; Shinde S; Wipf P; Lazo JS
    Assay Drug Dev Technol; 2007 Jun; 5(3):319-32. PubMed ID: 17638532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
    Menendez JA; Vellon L; Colomer R; Lupu R
    Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.